Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

University of Toronto

$10,000.00

6th Canadian Symposium on Telomeres and Genome Integrity

FY 2022-23

Summary
With nearly half of Canadians expected to be diagnosed with cancer during their lifetime, cancer is a disease that unfortunately is only too familiar with us. Due to demographic shifts, the incidence of cancer is predicted to increase and exert a massive toll on our society - physically, mentally, and economically. Cancer is a complex disease that manifests when our cells accumulate problems in several critical biological processes. Two prevalent traits of cancer cells are immortality and genome instability. The 6th Canadian Symposium on Telomeres and Genome Integrity will be held in Ontario (May 21-24, 2024). The organizers are Drs. Raymund Wellinger and Haley Wyatt. The overarching goal of this symposium is to provide a stimulating platform for Canadian scientists to meet and exchange ideas, establish scientific collaborations, and build bridges between academic researchers and the clinical or private sectors. This symposium is essential for the continued development of a strong Canadian telomere and genome integrity community, which will ensure that Canada maintains its international stake in cancer research. The symposium is a bi-annual event that was launched in 2014 with the declared goal of keeping Canada at the forefront of international efforts to understand the cellular mechanisms that safeguard genome integrity and prevent cancer development. The symposium is also an evolution of the founding Canadian Symposium on Telomeres and Telomerase (1997-2014). This forward-thinking expansion has brought together a larger audience with interests in telomere maintenance and genome integrity. Both fields converge on critical pathways involving cancer and aging and the added benefits from broader topics are extremely valuable in an era of collaborative research. The organizers and participants are enthusiastic about the opportunities and interactions that this meeting will bring for fundamental, clinical, and translational aspects of cancer research.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
480746
Name
Wyatt Haley D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
6th Canadian Symposium on Telomeres and Genome Integrity
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Aging; Cancer; Carcinogens; Chromosome Stability; Dna Damage; Dna Repair; Genome Integrity; National Symposium; Telomerase; Telomeres
Abstract
With nearly half of Canadians expected to be diagnosed with cancer during their lifetime, cancer is a disease that unfortunately is only too familiar with us. Due to demographic shifts, the incidence of cancer is predicted to increase and exert a massive toll on our society - physically, mentally, and economically. Cancer is a complex disease that manifests when our cells accumulate problems in several critical biological processes. Two prevalent traits of cancer cells are immortality and genome instability. The 6th Canadian Symposium on Telomeres and Genome Integrity will be held in Ontario (May 21-24, 2024). The organizers are Drs. Raymund Wellinger and Haley Wyatt. The overarching goal of this symposium is to provide a stimulating platform for Canadian scientists to meet and exchange ideas, establish scientific collaborations, and build bridges between academic researchers and the clinical or private sectors. This symposium is essential for the continued development of a strong Canadian telomere and genome integrity community, which will ensure that Canada maintains its international stake in cancer research. The symposium is a bi-annual event that was launched in 2014 with the declared goal of keeping Canada at the forefront of international efforts to understand the cellular mechanisms that safeguard genome integrity and prevent cancer development. The symposium is also an evolution of the founding Canadian Symposium on Telomeres and Telomerase (1997-2014). This forward-thinking expansion has brought together a larger audience with interests in telomere maintenance and genome integrity. Both fields converge on critical pathways involving cancer and aging and the added benefits from broader topics are extremely valuable in an era of collaborative research. The organizers and participants are enthusiastic about the opportunities and interactions that this meeting will bring for fundamental, clinical, and translational aspects of cancer research.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wyatt, Haley D
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $10,000~ $0~